31 maj: Neurosearch/Nordea: Sænker anbefaling til "sælg"
31 maj: Råvarer: Sydeuropæiske problemer får investorer til at sælge ud
31-05-2012 08:16:00

Prudential PLC Prudential Acquisition -2-

Relateret indhold

This release may contain 'forward-looking statements' with respect to certain of Prudential's plans and its goals and expectations relating to its future financial condition, performance, results, strategy and objectives. Statements that are not historical facts, including statements about Prudential's beliefs and expectations, are forward-looking statements. These statements are based on plans, estimates and projections as at the time they are made, and therefore undue reliance should not be placed on them. By their nature, all forward-looking statements involve risk and uncertainty. A number of important factors could cause Prudential's actual future financial condition or performance or other indicated results to differ materially from those indicated in any forward-looking statement. Such factors include, but are not limited to, future market conditions, fluctuations in interest rates and exchange rates, and the performance of financial markets generally; the policies and actions of regulatory authorities, including, for example, new government initiatives related to the financial crisis and the effect of the European Union's 'Solvency II' requirements on Prudential's capital maintenance requirements; the impact of competition, inflation, and deflation; experience in particular with regard to mortality and morbidity trends, lapse rates and policy renewal rates; the timing, impact and other uncertainties of future acquisitions or combinations within relevant industries; the impact of changes in capital, solvency standards or accounting standards, and tax and other legislation and regulations in the jurisdictions in which Prudential and its affiliates operate; and the impact of legal actions and disputes. These and other important factors may for example result in changes to assumptions used for determining results of operations or re-estimations of reserves for future policy benefits. Further discussion of these and other important factors that could cause Prudential's actual future financial condition or performance or other indicated results to differ, possibly materially, from those anticipated in Prudential's forward-looking statements can be found under the 'Risk factors' heading in the Annual Report and the 'Risk Factors' heading of Prudential's most recent annual report on Form 20-F filed with the U.S. Securities and Exchange Commission, as well as under the 'Risk Factors' heading of any subsequent Prudential Half Year Financial Report. Prudential's most recent Annual Report, Form 20-F and any subsequent Half Year Financial Report are/will be available on its website at www.prudential.co.uk.

Any forward-looking statements contained in this document speak only as of the date on which they are made. Prudential expressly disclaims any obligation to update the forward-looking statements contained in this document or any other forward-looking statements it may make, whether as a result of future events, new information or otherwise except as required pursuant to the UK Prospectus Rules, the UK Listing Rules, the UK Disclosure and Transparency Rules, the Hong Kong Listing Rules, the SGX-ST listing rules or other applicable laws and regulations.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACQGSGDUCBXBGDB

(END) Dow Jones Newswires

May 31, 2012 02:16 ET (06:16 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Zealand Pharma kan se frem til milepælsbetaling på 4 mio. euro

22-08-2017 16:00:43
Zealand Pharma kan se frem til at modtage 4 mia. euro (30 mio. kr.) som en milepælsbetaling, efter at selskabets tyske partner, Boehringer Ingelheim, har annonceret igangsætningen af to fase-1-studier med et midler udviklet af det danske biotekselskab.De to studier skal vise mulighederne for anvendelsen af medikamenterne til behandling af fedme og/eller diabetes. Det gælder blandt andet lægemiddel..

Matas/Danske: Regnskab med lavere omsætning var forventet

22-08-2017 13:53:03
Matas' regnskab for første kvartal i det forskudte regnskabsår 2017/2018 var som forventet.Det vurderer Poul Ernst Jessen, senioranalytiker i Danske Bank.- Regnskabet er som forventet. Det eneste overraskende er ledelsesændringen, siger Poul Ernst Jessen.Materialistkædens omsætning faldt 3,2 pct. til 820,9 mio. kr., mens driftsresultatet (EBITA) var 119 mio. kr. Danske Bank forventede en omsætning..

Mærsk: Oil-salg får analytikerne til at rykke på kursmålene

22-08-2017 11:39:54
Analytikerne har primært reageret positivt på A.P. Møller-Mærsks salg af Maersk Oil.Olie- og gasdivisionen sælges til franske Total for 7,45 mia. dollar, eller 47 mia. kr., og det var mere, end de fleste analytikere havde forudset. Den ekstra værdi lægges derfor i mange tilfælde oven i aktiekursen.Eksempelvis har Nykredit lagt 400 kr. til kursmålet alene fra Oil-salget, der var 8 mia. kr. over ana..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Mærsk: Oil-salg får analytikerne til at rykke på kursmålene
2
Bavarian får godkendt aftale med Janssen af amerikanske myndigheder
3
Aktier/tendens: Jyske Bank, Matas og Unibrew tager overskrifterne
4
Tirsdagens aktier: Pandora tog revanche og stor stigning i C20 Cap
5
Zealand Pharma kan se frem til milepælsbetaling på 4 mio. euro

Relaterede aktiekurser

Prudential PLC ORD 5P 1.818,23 0,9% Stigning i aktiekurs
Prudential Public Limite.. 46,66 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
23. august 2017 02:45:47
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170821.2 - EUROWEB2 - 2017-08-23 02:45:47 - 2017-08-23 02:45:47 - 1 - Website: OKAY